Mean Platelet Volume and STEMI Clinical Risk Scores in Prediction of Impaired Myocardial Perfusion In Acute STEMI Patients Undergoing Primary Percutaneous Coronary Intervention.
Completed
- Conditions
- No-Reflow Phenomenon
- Interventions
- Other: Mean platelet volume, lymphocyte number, STEMI clinical risk scores
- Registration Number
- NCT04785209
- Lead Sponsor
- Assiut University
- Brief Summary
Predicting no reflow in ppci of STEMI patients using mean platelet volume together with STEMI clinical risk scores
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 640
Inclusion Criteria
- patients presenting with acute STEMI, within 24 hours of symptoms, fulfilling criteria for PPCI protocol in our facility
Exclusion Criteria
- patients presenting more than 24 hours of symptoms onset
- patients not eligible for PPCI program in our facility
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description No reflow Mean platelet volume, lymphocyte number, STEMI clinical risk scores No reflow phenomenon after pci on STEMI patients, mean platelet volume, lymphocyte ratio, detailed echo within 24 hrs of admission, clinical STEMI risk scores No complication Mean platelet volume, lymphocyte number, STEMI clinical risk scores Thrombolysis in myocardial infarction flow grade III flow after PPCI, mean platelet volume, lymphocyte ratio, detailed echo within 24 hrs of admission, clinical STEMI risk scores
- Primary Outcome Measures
Name Time Method Number of participents with No reflow after PPCI and in hospital mortality Within 48 hours from admission No reflow: suboptimal myocardial reperfusion through a part of coronary circulation without angiographic evidence of mechanical vessel obstruction.
In hospital mortality
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Assiut university hospital
🇪🇬Assiut, Egypt